Correction to: Alz Res Therapy 13, 140 (2021)

https://doi.org/10.1186/s13195-021-00884-7

Following the publication of the original article [1] the authors noticed that the published Fig. 3 is incorrect. The original article [1] has been updated.

Below is the correct Fig. 3.

Fig. 3
figure 1

Modelling APOE separately, assuming the same effect of APOE-ε4 (OR ~ 3) in all age groups, and accounting for age related differences in frequency of APOE-ε4 allele (MAF = 0.18 in 55+ and MAF = 0.05 in 85+). In age group 65+ (left) the presence of APOE-ɛ4 allele increases the AD probability from 0.01 to 0.07 when PRS is the lowest and from 0.2 to 0.66 when the PRS is highest (top vs bottom lines). For 85+ age group (right), these values are 0.06 to 0.3 (low PRS) and 0.65 to 0.92 (high PRS)